Old Web
English
Sign In
Acemap
>
authorDetail
>
Jared Thorley
Jared Thorley
Huntsman Cancer Institute
Prostate cancer
Castration
Oncology
Enzalutamide
Internal medicine
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) versus EZ alone in metastatic castration-refractory prostate cancer (mCRPC): Long-term follow up of secondary endpoints.
2020
Journal of Clinical Oncology
Benjamin Louis Maughan
Andrew W. Hahn
Roberto H. Nussenzveig
John M. Hoffman
Kathryn A. Morton
Sumati Gupta
Julia A. Batten
Jared Thorley
Josiah Hawks
Victor Sacristan Santos
Gayatri Nachaegari
Xuechen Wang
Kenneth M. Boucher
Benjamin Haaland
Neeraj Agarwal
Show All
Source
Cite
Save
Citations (0)
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer.
2020
Clinical Cancer Research
Neeraj Agarwal
Roberto H. Nussenzveig
Andrew W. Hahn
John M. Hoffman
Kathryn A. Morton
Sumati Gupta
Julia A. Batten
Jared Thorley
Josiah L. Hawks
Victor Sacristan Santos
Gayatri Nachaegari
Xuechen Wang
Kenneth M. Boucher
Benjamin Haaland
Benjamin Louis Maughan
Show All
Source
Cite
Save
Citations (7)
Safety data from a phase II randomized trial of radium-223 dichloride (Ra-223) plus enzalutamide (Enza) vs. Enza alone in men with metastatic castration refractory prostate cancer (mCRPC).
2018
Journal of Clinical Oncology
Benjamin L. Maughan
John M. Hoffman
Kathryn A. Morton
Bhasker Rao Koppula
Julia A. Batten
Jared Thorley
Josiah Hawks
Kenneth M. Boucher
Neeraj Agarwal
Show All
Source
Cite
Save
Citations (2)
1